Skip to content

ORBIMED ADVISORS LLC: CRNX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on CRNX, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 0 CRNX shares at 2026-09-30 per its 13F-HR filed 2026-11-16.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 0 shares
    Change vs previous 13F -999,000 shares

    13F-HR 0001172661-26-005349 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

    Exited: the 13F for this period no longer lists the position.

  2. period ended2026-06-30
    13F 999,000 shares
    Change vs previous 13F 0 shares

    0.71% of the 13F portfolio, value $37,382,580.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 999,000 shares
    Change vs previous 13F 0 shares

    0.79% of the 13F portfolio, value $36,283,680.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-12-31
    13F 999,000 shares
    Change vs previous 13F -100,000 shares

    0.95% of the 13F portfolio, value $46,503,450.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-09-30
    13F 1,099,000 shares
    Change vs previous 13F -50,000 shares

    1.1% of the 13F portfolio, value $45,773,350.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-06-30
    13F 1,149,000 shares
    Change vs previous 13F +150,000 shares

    0.83% of the 13F portfolio, value $33,045,240.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2025-03-31
    13F 999,000 shares
    Change vs previous 13F 0 shares

    0.8% of the 13F portfolio, value $33,506,460.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-12-31
    13F 999,000 shares
    Change vs previous 13F not available

    1.06% of the 13F portfolio, value $51,078,870.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).